Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000343

Drug Information
NameScopolamine
SynonymsSDCCGMLS-0066589.P001; BPBio1_001049; Hyoscine bromide; Scopolaminhydrobromid; CAS-55-16-3; Atroscine Hydrobromide; IDI1_000291; AC1MIXH6; CHEBI:16794; Tropane alkaloid; CID2723877; NCI60_005415; Hyosol; Scop; Scopolammonium bromide; Spectrum4_000992; UNII-DL48G20X8X; 81D34684-E0B2-4B3A-A36C-FB916BBC90F7; HMS2090N13; BRD-A14566392-004-03-5; NCGC00024357-02; Scopine (-)-tropate; Atroquin; SCOPOLAMINE BROMIDE; NCI61806; LS-194418; MolPort-002-506-902; AKOS001581155; 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate; KBio1_000291; CID3000322; Scopine tropate; NCGC00024357-04; Prestwick0_000877; Spectrum_000950; CID10267087; Scopolamine Hyoscine; KBio2_003998; NSC-61806; CID5702114; 6,7-Epoxytropine tropate; CHEBI:111434; CID3081743; KBioGR_001423; SEE; SPBio_001405; MLS000758270; 58670-87-4; LS-144659; Hyocine F hydrobromide; CID6325382; (+)-Scopolamine; Isopto Hyoscine; NCGC00096833-01; nchembio.78-comp19; Scopolamine (INN); AC1L9QO2; CID10267079; KBioGR_001853; Tropic acid, 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(sup 2,4))non-7-yl ester; Transderm scop (TN); CID153311; D00138; NCGC00016245-01; Skopolamin; Prestwick2_000877; Spectrum5_001142; Atrochin; 6beta,7beta-Epoxy-1alpha,5alpha-tropan-3alpha-ol; Hyosceine; CID673473; CID11968014; CHEMBL253569; EINECS 200-090-3; Hydroscine hydrobromide; Tocris-1414; CID5184; KBio2_001430; CID452977; Transderm-V; Hysco; 28901-63-5; Isoscopil; CID6432494; 14797-94-5; Tranaxine; HSDB 4074; (+)-Hyoscine; Prestwick3_000877; AC-968; 138-12-5; BSPBio_000953; Tropic acid, ester with scopine; AC1L1L6Q; MolPort-005-938-576; CID638340; CHEMBL1201069; Prestwick1_000877; Scopamin; 3-Oxa-9-azatricyclo(3.3.1.0(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester); 226562-00-1; CID450840; 9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl tropate; NCGC00162334-01; CID6451257; NCGC00015932-02; KBio2_006566; Scopolaminium bromide; 51-34-3; Transcop; CID3246242; Oscine; 3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester); CID5809; Beldavrin; C01851; NINDS_000291; Epoxytropine tropate; NCGC00015932-01; (-)-Scopolamine; AR-1J2195; L001096; Spectrum4_001187; DivK1c_000291; Atroscine; SMR000449327; AC1L1JSC; CID6713754; BRD-K89923877-003-02-4; Scopos; 6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate; AC1MC3SI; DB00747; Lopac-S-1875; (-)-Hyoscine; AC1LDRGW; Hyoscine; NCGC00024357-05; AC1L4A4J; Euscopol; ZINC19796020; MOLI001381; 114-49-8; (1S,3S,5R,6R,7S)-6,7-epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate; KBioSS_001430; scopolamine; l-Scopolamine; CHEMBL608810; AC1Q60XM; NCGC00162334-02; NCGC00013722; Sereen; SMP1_000270; CID9916237; Triptone; Scopoderm-TTS; 97991-84-9; AC1LCW6T; Transderm scop; KBio3_001814; (-)-Scopolamine hydrobromide trihydrate; AC1MMY38; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epo; AC1L9P7Q; Spectrum2_001313; CID9808333; SPBio_002874; CID6604698; Transderm-Scop; AB00429689; CID10017965; Spectrum3_000897; xy-, (-)-tropate (ester); AC1MHD40; Kwells; Hyoscyine hydrobromide; LS-144660; MolPort-002-052-054; Lopac0_001076; l-Hyoscine hydrobromide; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester); 65319-33-7
Trade NameLevo-duboisine; hyoscine; burundanga; borrachero
CompanyNorvatis Phamaceuticals Corporation
IndicationNausea and Addiction
[ICD9: 303-305, 787.0   ICD10: F10-F19, R11]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-1
9)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12-,13-,14+,15-,1
6+/m1/s1/i17+2
InChIKeySTECJAGHUSJQJN-OHCMNABBSA-N
Canonical SMILESCN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4    
Isomeric SMILESCN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)O[14C](=O)[C@H](CO)C4=CC=CC=C4
Therapeutic ClassAntispasmodics
CAS NumberCAS 51-34-3
PubChem Compound IDCID 10267087.
PubChem Substance IDSID 15271797.
ChEBI16794;
SuperDrug ATC IDA04AD01; N05CM05; S01FA02
SuperDrug CAS ID000051343;
TargetMuscarinic acetylcholine receptor M2Antagonist[2][3]
Ref 1Drug Information of Calcidiol from NEXTBIO. To Reference
Ref 2The amygdala modulates morphine-induced state-dependent memory retrieval via muscarinic acetylcholine receptors. Neuroscience. 2009 May 5;160(2):255-63. Epub 2009 Mar 9. To Reference
Ref 3Midbrain acetylcholine and glutamate receptors modulate accumbal dopamine release. Neuroreport. 2008 Jun 11;19(9):991-5. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543